Anika Therapeutics | ANIK - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
Agenus USD 78.81M 16.47M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.63B 20.75M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 59.77B 601M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
MacroGenics USD 321.69M 139.16M 2026-06
Merit Medical Systems USD 1.11B 10.46M 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 31.52B 1.36B 2026-06
Smith & Nephew USD 4.39B 240M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Veracyte USD 574.78M 52.6M 2026-06
Xencor USD 523.21M 40.36M 2026-06
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06